Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2012, Article ID 543747, 4 pages
http://dx.doi.org/10.1155/2012/543747
Case Report

A Report of Nausea and Vomiting with Discontinuation of Chronic Use of Salvia divinorum

1Department of Pharmacy Practice, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USA
2Department of Internal Medicine, University of South Alabama, 650 Health Services Building, Suite 2100, Mobile, AL 36688, USA

Received 1 July 2011; Accepted 5 January 2012

Academic Editor: Yedidia Bentur

Copyright © 2012 C. R. Travis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. W. Johnson, K. A. MacLean, C. J. Reissig, T. E. Prisinzano, and R. R. Griffiths, “Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum,” Drug and Alcohol Dependence, vol. 115, no. 1-2, pp. 150–155, 2011. View at Publisher · View at Google Scholar
  2. M. J. Baggott, E. Erowid, F. Erowid, G. P. Galloway, and J. Mendelson, “Use patterns and self-reported effects of Salvia divinorum: an internet-based survey,” Drug and Alcohol Dependence, vol. 111, no. 3, pp. 250–256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. K. M. Babu, C. R. McCurdy, and E. W. Boyer, “Opioid receptors and legal highs: Salvia divinorum and Kratom,” Clinical Toxicology, vol. 46, no. 2, pp. 146–152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Imanshahidi and H. Hosseinzadeh, “The pharmacological effects of Salvia species on the central nervous system,” Phytotherapy Research, vol. 20, no. 6, pp. 427–437, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. González, J. Riba, J. C. Bouso, G. Gómez-Jarabo, and M. J. Barbanoj, “Pattern of use and subjective effects of Salvia divinorum among recreational users,” Drug and Alcohol Dependence, vol. 85, no. 2, pp. 157–162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. B. L. Roth, K. Baner, R. Westkaemper et al., “Salvinorin A: a potent naturally occurring nonnitrogenous κ opioid selective agonist,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11934–11939, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. A. A. Jenks, J. B. Walker, and S. C. Kim, “Evolution and origins of the Mazatec hallucinogenic sage, Salvia divinorum (Lamiaceae): a molecular phylogenetic approach,” Journal of Plant Research, vol. 124, no. 5, pp. 593–600, 2011. View at Publisher · View at Google Scholar
  8. P. P. Nyi, E. P. Lai, D. Y. Lee, S. A. Biglete, G. I. Torrecer, and I. B. Anderson, “Influence of age on Salvia divinorum use: results of an Internet survey,” Journal of Psychoactive Drugs, vol. 42, no. 3, pp. 385–392, 2010. View at Google Scholar
  9. C. E. Dennehy, C. Tsourounis, and A. E. Miller, “Evaluation of herbal dietary supplements marketed on the internet for recreational use,” Annals of Pharmacotherapy, vol. 39, no. 10, pp. 1634–1639, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Fichna, R. Schicho, C. N. Andrews et al., “Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating κ-opioid and cannabinoid receptors,” Neurogastroenterology and Motility, vol. 21, no. 12, pp. 1326–e127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Fichna, R. Schicho, A. Janecka, J. K. Zjawiony, and M. Storr, “Selective natural κ opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction,” Drug News and Perspectives, vol. 22, no. 7, pp. 383–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Vohra, A. Seefeld, F. L. Cantrell, and R. F. Clark, “Salvia divinorum: exposures reported to a statewide poison control system over 10 years,” Journal of Emergency Medicine, vol. 40, no. 6, pp. 643–650, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. H. B. Gutstein and H. Akil, “Opioid analgesics,” in The Pharmacological Basis of Therapeutics, L. L. Brunton, J. S. Lazo, and K. L. Parker, Eds., pp. 547–590, McGraw Hill, New York, NY, USA, 11th edition, 2006. View at Google Scholar